Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 37% ± 16% |
Insufficient scRNA-seq data for expression of RTN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 820.48 | 239 / 245 | 98% | 13.71 | 494 / 502 |
brain | 96% | 2198.04 | 2538 / 2642 | 99% | 15.01 | 700 / 705 |
skin | 96% | 560.26 | 1729 / 1809 | 98% | 14.83 | 461 / 472 |
bladder | 100% | 619.57 | 21 / 21 | 87% | 8.99 | 439 / 504 |
adrenal gland | 91% | 610.47 | 234 / 258 | 91% | 14.90 | 210 / 230 |
breast | 89% | 608.48 | 410 / 459 | 92% | 14.44 | 1029 / 1118 |
lung | 86% | 439.20 | 495 / 578 | 85% | 6.96 | 978 / 1155 |
intestine | 87% | 717.99 | 844 / 966 | 80% | 6.59 | 423 / 527 |
esophagus | 80% | 576.94 | 1150 / 1445 | 83% | 6.51 | 152 / 183 |
uterus | 64% | 458.34 | 109 / 170 | 83% | 8.50 | 381 / 459 |
stomach | 56% | 287.98 | 202 / 359 | 81% | 7.11 | 233 / 286 |
kidney | 44% | 187.64 | 39 / 89 | 75% | 4.90 | 678 / 901 |
thymus | 51% | 187.07 | 330 / 653 | 65% | 3.74 | 393 / 605 |
pancreas | 13% | 43.60 | 41 / 328 | 98% | 12.67 | 174 / 178 |
muscle | 100% | 8534.89 | 803 / 803 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.26 | 1 / 1 |
eye | 0% | 0 | 0 / 0 | 99% | 17.34 | 79 / 80 |
ovary | 9% | 36.79 | 17 / 180 | 88% | 9.03 | 378 / 430 |
spleen | 97% | 648.81 | 234 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 11.75 | 28 / 29 |
heart | 90% | 589.93 | 778 / 861 | 0% | 0 | 0 / 0 |
adipose | 90% | 474.82 | 1085 / 1204 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 80% | 5.62 | 36 / 45 |
blood vessel | 73% | 372.95 | 979 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 65% | 525.16 | 600 / 929 | 0% | 0 | 0 / 0 |
liver | 5% | 17.87 | 12 / 226 | 59% | 5.98 | 240 / 406 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1902430 | Biological process | negative regulation of amyloid-beta formation |
GO_0065002 | Biological process | intracellular protein transmembrane transport |
GO_0010467 | Biological process | gene expression |
GO_0046324 | Biological process | regulation of glucose import |
GO_0014802 | Cellular component | terminal cisterna |
GO_0009986 | Cellular component | cell surface |
GO_0033017 | Cellular component | sarcoplasmic reticulum membrane |
GO_0030315 | Cellular component | T-tubule |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0030018 | Cellular component | Z disc |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0005882 | Cellular component | intermediate filament |
GO_0005515 | Molecular function | protein binding |
Gene name | RTN2 |
Protein name | Reticulon-2 (Neuroendocrine-specific protein-like 1) (NSP-like protein 1) (Neuroendocrine-specific protein-like I) (NSP-like protein I) (NSPLI) Truncated RTN2-A2 Reticulon 2 (Truncated RTN2-B2) Reticulon |
Synonyms | NSPL1 hCG_1996624 |
Description | FUNCTION: Inhibits amyloid precursor protein processing, probably by blocking BACE1 activity . Enhances trafficking of the glutamate transporter SLC1A1/EAAC1 from the endoplasmic reticulum to the cell surface (By similarity). Plays a role in the translocation of SLC2A4/GLUT4 from intracellular membranes to the cell membrane which facilitates the uptake of glucose into the cell (By similarity). . |
Accessions | Q6GMT0 ENST00000591286.5 ENST00000590526.5 ENST00000430715.6 [O75298-3] ENST00000587597.5 Q7RTN0 K7EMR7 ENST00000245923.9 [O75298-1] Q96CG9 O75298 Q7RTM9 ENST00000344680.8 [O75298-2] |